Clinical Trials Market Size and Forecast (2021 – 2031)
Clinical Trials Market Size and Forecast (2021 – 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Study Design (Interventional Trials and Expanded Access Trials), Indications (Autoimmune Diseases/Inflammation, Pain Management, Oncological Conditions, Neurological Disorders, Diabetes, Obesity, Metabolic Disorders, Cardiovascular Diseases, and Others), Phase Type (Phase I, Phase II, and Phase III), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
$3,633 – $6,433
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Clinical trials are research studies that test a medical, surgical, or behavioral intervention in people. These trials are the primary way that researchers determine if a new form of treatment or prevention, such as a new drug, diet, or medical device (for example, a pacemaker), is safe and effective in people. Often, a clinical trial is designed to learn if a new treatment is more effective or has less harmful side effects than existing treatments.
North America accounted for a major share of the global clinical trials market in 2023. The clinical trials market in North America is segmented into the US, Canada, and Mexico. The US has become a leading clinical research destination. Nearly half of the clinical trials are conducted in the US. Additionally, most pharmaceutical research companies prefer to conduct clinical trials in the US due to established medical infrastructure, rapid approval timelines, a favorable regulatory framework, and accepted clinical trial-generated data globally. A World Health Organization (WHO) report states that the US had the highest number of clinical trials, with 157,618 trials in 2021.
The growth of the clinical trials market in the US can be attributed to innovative products launched by companies for applications in clinical trials. Medical Metrics, a clinical research organization (CRO) providing various services for clinical trials, offers “Assessa.” This product assists in the decision-making process of drug discovery and related clinical studies. It helps discover drugs for neurological disorders, such as dementia, cognitive impairment, Alzheimer’s disease, Parkinson’s Disease, Schizophrenia, and other memory-related diseases. The rising number of clinical trials in the US favors the growth of the clinical trials market in the country.
Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials to Provide Market Opportunities in Future
Subjects enrolled in decentralized clinical trials (DCT) do not need to access hospital-based trial sites frequently. In DCTs, digital technologies are used to enable access of patients for clinical research, remote data collection and monitoring, and communication between investigators and participants. A hybrid clinical trial approach combines home-based and on-site activities, bringing the best patient experience and meeting complex protocol regimes, gaining traction across various therapeutic areas and trial phase journeys. Initially, the adoption of DCT was affected due to challenges such as patient privacy, data security, regulatory barriers, and complex protocol regimes. However, the COVID-19 pandemic compelled the sponsors of clinical trials to adopt decentralized and hybrid clinical techniques for developing drugs, as in-person studies were not feasible amid this health crisis. With restrictions imposed on commute, the only way to gather data and keep trials going was to work remotely and make optimal use of technologies to accelerate processes. According to the data provided by McKinsey, ~70% of the potential participants for clinical trials stay away from trial sites. Therefore, decentralization broadens trial access to reach a larger number of subjects, consisting of potentially a more diverse pool of patients.
Hybrid clinical trials allow sponsors to strategically incorporate DCT elements into study designs. These trial models offer unprecedented flexibility; thus, more companies are showing interest in hybrid trials, which is redefining the industry landscape. According to ObvioHealth, the FDA had plans to unveil protocols to support the use of DCT methods in 2023 to enhance the credibility of future clinical research. Thus, the increasing focus on using decentralized and hybrid clinical trials over traditional clinical trial methods is expected to provide lucrative opportunities for the clinical trials market during the forecast period.
Study Design -Based Insights
Based on study design, the market is bifurcated into interventional trials and expanded access trials.
Indication -Based Insights
By indication, the market is segmented into cardiovascular diseases, oncological conditions, neurological disorders, autoimmune diseases/inflammation, pain management, diabetes, obesity, metabolic disorders, and others.
Phase -Based Insights
Based on phase, the clinical trials market is divided into Phase I, Phase II, and Phase III.
Clinical Trials Market: Competitive Landscape and Key Developments
IQVIA Holdings Inc, Parexel International Corporation, IXICO Plc, Charles River Laboratories Inc, ICON Plc, WuXi AppTec Co Ltd, SGS SA, Syneos Health Inc, SIRO Clinpharm Private Limited, Thermo Fisher Scientific Inc, Laboratory Corp of America Holdings, CliniRx, Caidya, Oracle Corp, and Medpace are among the key companies operating in the clinical trials market.
The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the clinical trials market report.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the global clinical trials market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Clinical Trials Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Clinical Trials Market – Key Market Dynamics
5.1 Clinical Trials Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Practice of Outsourcing Clinical Studies with Massive Rise in Number of Trials
5.2.2 Flourishing Pharmaceutical Industry with Surge in R&D Activities
5.3 Market Restraints
5.3.1 Expensive and Time-Consuming Process
5.4 Market Opportunities
5.4.1 Adoption of Decentralized Clinical Trials and Hybrid Clinical Trials
5.5 Future Trends
5.5.1 AI-Driven Clinical Trials
5.6 Impact of Drivers and Restraints:
6. Clinical Trials Market – Global Market Analysis
6.1 Clinical Trials Market Revenue (US$ Million), 2021–2031
6.2 Global Clinical Trials Market Forecast Analysis
7. Clinical Trials Market Analysis – by Study Design
7.1 Interventional Trials
7.1.1 Overview
7.1.2 Interventional Trials: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Expanded Access Trials
7.2.1 Overview
7.2.2 Expanded Access Trials: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
8. Clinical Trials Market Analysis – by Indications
8.1 Autoimmune Diseases/Inflammation
8.1.1 Overview
8.1.2 Autoimmune Diseases/Inflammation : Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Pain Management
8.2.1 Overview
8.2.2 Pain Management: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Oncological Conditions
8.3.1 Overview
8.3.2 Oncological Conditions: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Neurological Disorders
8.4.1 Overview
8.4.2 Neurological Disorders: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Diabetes
8.5.1 Overview
8.5.2 Diabetes: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
8.6 Obesity
8.6.1 Overview
8.6.2 Obesity: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
8.7 Metabolic Disorders
8.7.1 Overview
8.7.2 Metabolic Disorders: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
8.8 Cardiovascular Diseases
8.8.1 Overview
8.8.2 Cardiovascular Diseases: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
9. Clinical Trials Market Analysis – by Phase
9.1 Phase I
9.1.1 Overview
9.1.2 Phase I: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Phase II
9.2.1 Overview
9.2.2 Phase II: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Phase III
9.3.1 Overview
9.3.2 Phase III: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10. Clinical Trials Market – Geographical Analysis
10.1 Overview
10.2 North America
10.2.1 North America Clinical Trials Market Overview
10.2.2 North America: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.2.2.1 North America: Clinical Trials Market – Revenue and Forecast Analysis – by Study Design
10.2.2.2 North America: Clinical Trials Market – Revenue and Forecast Analysis – by Indications
10.2.2.3 North America: Clinical Trials Market – Revenue and Forecast Analysis – by Phase
10.2.3 North America: Clinical Trials Market – Revenue and Forecast Analysis – by Country
10.2.3.1 United States: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.1.1 United States: Clinical Trials Market Breakdown, by Study Design
10.2.3.1.2 United States: Clinical Trials Market Breakdown, by Indications
10.2.3.1.3 United States: Clinical Trials Market Breakdown, by Phase
10.2.3.2 Canada: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.2.1 Canada: Clinical Trials Market Breakdown, by Study Design
10.2.3.2.2 Canada: Clinical Trials Market Breakdown, by Indications
10.2.3.2.3 Canada: Clinical Trials Market Breakdown, by Phase
10.2.3.3 Mexico: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.3.1 Mexico: Clinical Trials Market Breakdown, by Study Design
10.2.3.3.2 Mexico: Clinical Trials Market Breakdown, by Indications
10.2.3.3.3 Mexico: Clinical Trials Market Breakdown, by Phase
10.3 Europe
10.3.1 Europe Clinical Trials Market Overview
10.3.2 Europe: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.3.2.1 Europe: Clinical Trials Market – Revenue and Forecast Analysis – by Study Design
10.3.2.2 Europe: Clinical Trials Market – Revenue and Forecast Analysis – by Indications
10.3.2.3 Europe: Clinical Trials Market – Revenue and Forecast Analysis – by Phase
10.3.3 Europe: Clinical Trials Market – Revenue and Forecast Analysis – by Country
10.3.3.1 United Kingdom: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.1.1 United Kingdom: Clinical Trials Market Breakdown, by Study Design
10.3.3.1.2 United Kingdom: Clinical Trials Market Breakdown, by Indications
10.3.3.1.3 United Kingdom: Clinical Trials Market Breakdown, by Phase
10.3.3.2 Germany: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.2.1 Germany: Clinical Trials Market Breakdown, by Study Design
10.3.3.2.2 Germany: Clinical Trials Market Breakdown, by Indications
10.3.3.2.3 Germany: Clinical Trials Market Breakdown, by Phase
10.3.3.3 France: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.3.1 France: Clinical Trials Market Breakdown, by Study Design
10.3.3.3.2 France: Clinical Trials Market Breakdown, by Indications
10.3.3.3.3 France: Clinical Trials Market Breakdown, by Phase
10.3.3.4 Spain: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.4.1 Spain: Clinical Trials Market Breakdown, by Study Design
10.3.3.4.2 Spain: Clinical Trials Market Breakdown, by Indications
10.3.3.4.3 Spain: Clinical Trials Market Breakdown, by Phase
10.3.3.5 Italy: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.5.1 Italy: Clinical Trials Market Breakdown, by Study Design
10.3.3.5.2 Italy: Clinical Trials Market Breakdown, by Indications
10.3.3.5.3 Italy: Clinical Trials Market Breakdown, by Phase
10.3.3.6 Poland: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.6.1 Poland: Clinical Trials Market Breakdown, by Study Design
10.3.3.6.2 Poland: Clinical Trials Market Breakdown, by Indications
10.3.3.6.3 Poland: Clinical Trials Market Breakdown, by Phase
10.3.3.7 Switzerland: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.7.1 Switzerland: Clinical Trials Market Breakdown, by Study Design
10.3.3.7.2 Switzerland: Clinical Trials Market Breakdown, by Indications
10.3.3.7.3 Switzerland: Clinical Trials Market Breakdown, by Phase
10.3.3.8 Sweden: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.8.1 Sweden: Clinical Trials Market Breakdown, by Study Design
10.3.3.8.2 Sweden: Clinical Trials Market Breakdown, by Indications
10.3.3.8.3 Sweden: Clinical Trials Market Breakdown, by Phase
10.3.3.9 Denmark: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.9.1 Denmark: Clinical Trials Market Breakdown, by Study Design
10.3.3.9.2 Denmark: Clinical Trials Market Breakdown, by Indications
10.3.3.9.3 Denmark: Clinical Trials Market Breakdown, by Phase
10.3.3.10 Belgium: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.10.1 Belgium: Clinical Trials Market Breakdown, by Study Design
10.3.3.10.2 Belgium: Clinical Trials Market Breakdown, by Indications
10.3.3.10.3 Belgium: Clinical Trials Market Breakdown, by Phase
10.3.3.11 Netherlands: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.11.1 Netherlands: Clinical Trials Market Breakdown, by Study Design
10.3.3.11.2 Netherlands: Clinical Trials Market Breakdown, by Indications
10.3.3.11.3 Netherlands: Clinical Trials Market Breakdown, by Phase
10.3.3.12 Rest of Europe: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.12.1 Rest of Europe: Clinical Trials Market Breakdown, by Study Design
10.3.3.12.2 Rest of Europe: Clinical Trials Market Breakdown, by Indications
10.3.3.12.3 Rest of Europe: Clinical Trials Market Breakdown, by Phase
10.4 Asia Pacific
10.4.1 Asia Pacific Clinical Trials Market Overview
10.4.2 Asia Pacific: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.4.2.1 Asia Pacific: Clinical Trials Market – Revenue and Forecast Analysis – by Study Design
10.4.2.2 Asia Pacific: Clinical Trials Market – Revenue and Forecast Analysis – by Indications
10.4.2.3 Asia Pacific: Clinical Trials Market – Revenue and Forecast Analysis – by Phase
10.4.3 Asia Pacific: Clinical Trials Market – Revenue and Forecast Analysis – by Country
10.4.3.1 China: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3.1.1 China: Clinical Trials Market Breakdown, by Study Design
10.4.3.1.2 China: Clinical Trials Market Breakdown, by Indications
10.4.3.1.3 China: Clinical Trials Market Breakdown, by Phase
10.4.3.2 Japan: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3.2.1 Japan: Clinical Trials Market Breakdown, by Study Design
10.4.3.2.2 Japan: Clinical Trials Market Breakdown, by Indications
10.4.3.2.3 Japan: Clinical Trials Market Breakdown, by Phase
10.4.3.3 India: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3.3.1 India: Clinical Trials Market Breakdown, by Study Design
10.4.3.3.2 India: Clinical Trials Market Breakdown, by Indications
10.4.3.3.3 India: Clinical Trials Market Breakdown, by Phase
10.4.3.4 Australia: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3.4.1 Australia: Clinical Trials Market Breakdown, by Study Design
10.4.3.4.2 Australia: Clinical Trials Market Breakdown, by Indications
10.4.3.4.3 Australia: Clinical Trials Market Breakdown, by Phase
10.4.3.5 South Korea: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3.5.1 South Korea: Clinical Trials Market Breakdown, by Study Design
10.4.3.5.2 South Korea: Clinical Trials Market Breakdown, by Indications
10.4.3.5.3 South Korea: Clinical Trials Market Breakdown, by Phase
10.4.3.6 Indonesia: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3.6.1 Indonesia: Clinical Trials Market Breakdown, by Study Design
10.4.3.6.2 Indonesia: Clinical Trials Market Breakdown, by Indications
10.4.3.6.3 Indonesia: Clinical Trials Market Breakdown, by Phase
10.4.3.7 Malaysia: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3.7.1 Malaysia: Clinical Trials Market Breakdown, by Study Design
10.4.3.7.2 Malaysia: Clinical Trials Market Breakdown, by Indications
10.4.3.7.3 Malaysia: Clinical Trials Market Breakdown, by Phase
10.4.3.8 Singapore: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3.8.1 Singapore: Clinical Trials Market Breakdown, by Study Design
10.4.3.8.2 Singapore: Clinical Trials Market Breakdown, by Indications
10.4.3.8.3 Singapore: Clinical Trials Market Breakdown, by Phase
10.4.3.9 Rest of APAC: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.4.3.9.1 Rest of APAC: Clinical Trials Market Breakdown, by Study Design
10.4.3.9.2 Rest of APAC: Clinical Trials Market Breakdown, by Indications
10.4.3.9.3 Rest of APAC: Clinical Trials Market Breakdown, by Phase
10.5 Middle East and Africa
10.5.1 Middle East and Africa Clinical Trials Market Overview
10.5.2 Middle East and Africa: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.5.2.1 Middle East and Africa: Clinical Trials Market – Revenue and Forecast Analysis – by Study Design
10.5.2.2 Middle East and Africa: Clinical Trials Market – Revenue and Forecast Analysis – by Indications
10.5.2.3 Middle East and Africa: Clinical Trials Market – Revenue and Forecast Analysis – by Phase
10.5.3 Middle East and Africa: Clinical Trials Market – Revenue and Forecast Analysis – by Country
10.5.3.1 Saudi Arabia: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3.1.1 Saudi Arabia: Clinical Trials Market Breakdown, by Study Design
10.5.3.1.2 Saudi Arabia: Clinical Trials Market Breakdown, by Indications
10.5.3.1.3 Saudi Arabia: Clinical Trials Market Breakdown, by Phase
10.5.3.2 South Africa: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3.2.1 South Africa: Clinical Trials Market Breakdown, by Study Design
10.5.3.2.2 South Africa: Clinical Trials Market Breakdown, by Indications
10.5.3.2.3 South Africa: Clinical Trials Market Breakdown, by Phase
10.5.3.3 United Arab Emirates: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3.3.1 United Arab Emirates: Clinical Trials Market Breakdown, by Study Design
10.5.3.3.2 United Arab Emirates: Clinical Trials Market Breakdown, by Indications
10.5.3.3.3 United Arab Emirates: Clinical Trials Market Breakdown, by Phase
10.5.3.4 Rest of Middle East and Africa: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3.4.1 Rest of Middle East and Africa: Clinical Trials Market Breakdown, by Study Design
10.5.3.4.2 Rest of Middle East and Africa: Clinical Trials Market Breakdown, by Indications
10.5.3.4.3 Rest of Middle East and Africa: Clinical Trials Market Breakdown, by Phase
10.6 South and Central America
10.6.1 South and Central America Clinical Trials Market Overview
10.6.2 South and Central America: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.6.2.1 South and Central America: Clinical Trials Market – Revenue and Forecast Analysis – by Study Design
10.6.2.2 South and Central America: Clinical Trials Market – Revenue and Forecast Analysis – by Indications
10.6.2.3 South and Central America: Clinical Trials Market – Revenue and Forecast Analysis – by Phase
10.6.3 South and Central America: Clinical Trials Market – Revenue and Forecast Analysis – by Country
10.6.3.1 Brazil: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3.1.1 Brazil: Clinical Trials Market Breakdown, by Study Design
10.6.3.1.2 Brazil: Clinical Trials Market Breakdown, by Indications
10.6.3.1.3 Brazil: Clinical Trials Market Breakdown, by Phase
10.6.3.2 Argentina: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3.2.1 Argentina: Clinical Trials Market Breakdown, by Study Design
10.6.3.2.2 Argentina: Clinical Trials Market Breakdown, by Indications
10.6.3.2.3 Argentina: Clinical Trials Market Breakdown, by Phase
10.6.3.3 Rest of South and Central America: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3.3.1 Rest of South and Central America: Clinical Trials Market Breakdown, by Study Design
10.6.3.3.2 Rest of South and Central America: Clinical Trials Market Breakdown, by Indications
10.6.3.3.3 Rest of South and Central America: Clinical Trials Market Breakdown, by Phase
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Clinical Trials Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 QVIA Holdings Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Parexel International Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 IXICO Plc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Charles River Laboratories International Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 ICON Plc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 WuXi AppTec Co Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 SGS SA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Syneos Health Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 SIRO Clinpharm Pvt Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Thermo Fisher Scientific Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Laboratory Corp of America Holdings
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 CliniRx Research Private Limited
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 Caidya
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
12.14 Oracle Corp
12.14.1 Key Facts
12.14.2 Business Description
12.14.3 Products and Services
12.14.4 Financial Overview
12.14.5 SWOT Analysis
12.14.6 Key Developments
12.15 Medpace Holdings Inc
12.15.1 Key Facts
12.15.2 Business Description
12.15.3 Products and Services
12.15.4 Financial Overview
12.15.5 SWOT Analysis
12.15.6 Key Developments
13. Appendix
13.1 About The the Reporting Teams
13.2 Glossary of Terms
Table 1. Clinical Trials Market Segmentation
Table 2. R&D Investments by Major Pharmaceutical Companies
Table 3. North America: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 4. North America: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 5. North America: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 6. United States: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 7. United States: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 8. United States: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 9. Canada: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 10. Canada: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 11. Canada: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 12. Mexico: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 13. Mexico: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 14. Mexico: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 15. Europe: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 16. Europe: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 17. Europe: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 18. United Kingdom: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 19. United Kingdom: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 20. United Kingdom: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 21. Germany: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 22. Germany: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 23. Germany: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 24. France: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 25. France: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 26. France: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 27. Spain: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 28. Spain: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 29. Spain: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 30. Italy: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 31. Italy: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 32. Italy: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 33. Poland: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 34. Poland: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 35. Poland: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 36. Switzerland: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 37. Switzerland: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 38. Switzerland: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 39. Sweden: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 40. Sweden: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 41. Sweden: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 42. Denmark: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 43. Denmark: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 44. Denmark: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 45. Belgium: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 46. Belgium: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 47. Belgium: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 48. Netherlands: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 49. Netherlands: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 50. Netherlands: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 51. Rest of Europe: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 52. Rest of Europe: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 53. Rest of Europe: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 54. Asia Pacific: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 55. Asia Pacific: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 56. Asia Pacific: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 57. China: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 58. China: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 59. China: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 60. Japan: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 61. Japan: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 62. Japan: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 63. India: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 64. India: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 65. India: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 66. Australia: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 67. Australia: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 68. Australia: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 69. South Korea: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 70. South Korea: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 71. South Korea: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 72. Indonesia: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 73. Indonesia: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 74. Indonesia: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 75. Malaysia: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 76. Malaysia: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 77. Malaysia: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 78. Singapore: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 79. Singapore: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 80. Singapore: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 81. Rest of APAC: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 82. Rest of APAC: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 83. Rest of APAC: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 84. Middle East and Africa: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 85. Middle East and Africa: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 86. Middle East and Africa: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 87. Saudi Arabia: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 88. Saudi Arabia: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 89. Saudi Arabia: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 90. South Africa: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 91. South Africa: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 92. South Africa: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 93. United Arab Emirates: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 94. United Arab Emirates: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 95. United Arab Emirates: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 96. Rest of Middle East and Africa: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 97. Rest of Middle East and Africa: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 98. Rest of Middle East and Africa: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 99. South and Central America: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 100. South and Central America: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 101. South and Central America: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 102. Brazil: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 103. Brazil: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 104. Brazil: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 105. Argentina: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 106. Argentina: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 107. Argentina: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 108. Rest of South and Central America: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Study Design
Table 109. Rest of South and Central America: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Indications
Table 110. Rest of South and Central America: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million) – by Phase
Table 111. Recent Organic Growth Strategies in Clinical Trials Market
Table 112. Recent Inorganic Growth Strategies in the Clinical Trials Market
Table 113. Glossary of Terms, Clinical Trials Market
Figure 1. Clinical Trials Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Clinical Trials Market Revenue (US$ Million), 2021–2031
Figure 5. Clinical Trials Market Share (%) – by Study Design (2023 and 2031)
Figure 6. Interventional Trials: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Expanded Access Trials: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Clinical Trials Market Share (%) – by Indications (2023 and 2031)
Figure 9. Autoimmune Diseases/Inflammation : Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
Figure 10. Pain Management: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Oncological Conditions: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Neurological Disorders: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Diabetes: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Obesity: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Metabolic Disorders: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Cardiovascular Diseases: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Others: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. Clinical Trials Market Share (%) – by Phase (2023 and 2031)
Figure 19. Phase I: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Phase II: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. Phase III: Clinical Trials Market – Revenue and Forecast to 2031 (US$ Million)
Figure 22. Clinical Trials Market Breakdown by Region, 2023 and 2031 (%)
Figure 23. North America: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 24. North America: Clinical Trials Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 25. United States: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 26. Canada: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 27. Mexico: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 28. Europe: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 29. Europe: Clinical Trials Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 30. United Kingdom: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 31. Germany: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 32. France: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. Spain: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 34. Italy: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 35. Poland: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 36. Switzerland: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 37. Sweden: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 38. Denmark: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 39. Belgium: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 40. Netherlands: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 41. Rest of Europe: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 42. Asia Pacific: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. Asia Pacific: Clinical Trials Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 44. China: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 45. Japan: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 46. India: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 47. Australia: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 48. South Korea: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 49. Indonesia: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 50. Malaysia: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 51. Singapore: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 52. Rest of APAC: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 53. Middle East and Africa: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 54. Middle East and Africa: Clinical Trials Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 55. Saudi Arabia: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 56. South Africa: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 57. United Arab Emirates: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 58. Rest of Middle East and Africa: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 59. South and Central America: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 60. South and Central America: Clinical Trials Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 61. Brazil: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 62. Argentina: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 63. Rest of South and Central America: Clinical Trials Market – Revenue and Forecast to 2031(US$ Million)
Figure 64. Growth Strategies in Clinical Trials Market
The List of Companies – Clinical Trials Market
o IQVIA Holdings Inc
o Parexel International Corp
o IXICO Plc
o Charles River Laboratories International Inc
o ICON Plc
o WuXi AppTec Co Ltd,
o SGS SA
o Syneos Health Inc
o SIRO Clinpharm Pvt Ltd
o Thermo Fisher Scientific Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.